Prophylactic HPV vaccines: new interventions for cancer control
E Barr, HL Sings - Vaccine, 2008 - Elsevier
Human Papillomavirus (HPV) infection causes cervical cancer, a significant portion of anal,
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …
vulvar, vaginal, and oropharyngeal cancers, genital warts, and recurrent respiratory …
A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US
EF Dunne, SD Datta, L E. Markowitz - Cancer, 2008 - Wiley Online Library
It has been estimated that genital human papillomavirus (HPV) is the most common sexually
transmitted infection in the US. Nononcogenic types, such as HPV type 6 (HPV‐6) and HPV …
transmitted infection in the US. Nononcogenic types, such as HPV type 6 (HPV‐6) and HPV …
Indications and efficacy of the human papillomavirus vaccine
AA Hakim, PS Lin, S Wilczynski, K Nguyen… - … treatment options in …, 2007 - Springer
Opinion statement In the United States, there are 11,150 cases and 3670 deaths projected
due to invasive cervical cancer for 2007. Approximately 500,000 new cases and 274,000 …
due to invasive cervical cancer for 2007. Approximately 500,000 new cases and 274,000 …
Prophylactic HPV vaccination: past, present, and future
Human papillomavirus (HPV) is the necessary cause of cervical cancer, the fourth most
common cancer and cause of cancer-related death in females worldwide. HPV also causes …
common cancer and cause of cancer-related death in females worldwide. HPV also causes …
[HTML][HTML] Human papillomavirus (HPV), HPV-related disease, and the HPV vaccine
KP Braaten, MR Laufer - Reviews in obstetrics and gynecology, 2008 - ncbi.nlm.nih.gov
Human papillomavirus (HPV) is the most common sexually transmitted infection in the
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …
United States, and persistent HPV infection is strongly associated with risk of cervical cancer …
Quadrivalent human papillomavirus vaccine
B Gellin, JF Modlin, E Barr… - Clinical Infectious …, 2007 - academic.oup.com
The lifetime risk of human papillomavirus (HPV) infection exceeds 50%. HPV infection
causes> 550,000 cases of cervical and anogenital cancer worldwide annually. Infection also …
causes> 550,000 cases of cervical and anogenital cancer worldwide annually. Infection also …
Introducing human papillomavirus vaccines—questions remain
J Paavonen, M Lehtinen - Annals of Medicine, 2008 - Taylor & Francis
Genital human papillomavirus (HPV) infection and HPV‐associated cervical and other
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …
anogenital cancers are significant public health problems. HPV 16 and HPV 18 are …
Monitoring of human papillomavirus vaccination
J Dillner, M Arbyn, E Unger… - Clinical & Experimental …, 2011 - academic.oup.com
Persistent infection with oncogenic human papillomavirus (HPV) is a necessary causal
factor in the development of cervical cancer. Moreover, HPV, predominately type 16 and to a …
factor in the development of cervical cancer. Moreover, HPV, predominately type 16 and to a …
Human papillomavirus vaccination
JT Cox, JM Palefsky - UpToDate. Waltham, MA. Accessed September, 2018 - uptodate.com
INTRODUCTION—Human papillomavirus (HPV) is a sexually transmitted pathogen that
causes anogenital and oropharyngeal disease in males and females. Persistent viral …
causes anogenital and oropharyngeal disease in males and females. Persistent viral …
Clinical trials of human papillomavirus vaccines and beyond
M Lehtinen, J Dillner - Nature reviews Clinical oncology, 2013 - nature.com
Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …
14 oncogenic types are causally associated with 5–10% of all cancers. The major structural …